CCNE2 and neoplasm: hsa-miR-30d-5p, identified as a broad-spectrum candidate for diagnostic and therapeutic studies, regulates cellular functions through downstream targets like PI3K/AKT and cyclin E2 (CCNE2), and its dysregulation is linked to tumor development [[45], [46], [47], [48], [49], [50]].